These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21685299)

  • 21. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
    Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
    Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study.
    Valenzuela A; Baron M; ; Herrick AL; Proudman S; Stevens W; ; Rodriguez-Reyna TS; Vacca A; Medsger TA; Hinchcliff M; Hsu V; Wu JY; Fiorentino D; Chung L
    Semin Arthritis Rheum; 2016 Dec; 46(3):344-349. PubMed ID: 27371996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary survival study in 91 patients with systemic sclerosis.
    Poormoghim H; Lakeh MM; Mohammadipour M; Talehy-Moineddin S; Sodagari F
    Rheumatol Int; 2011 Dec; 31(12):1577-82. PubMed ID: 20496069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
    Alharbi S; Ahmad Z; Bookman AA; Touma Z; Sanchez-Guerrero J; Mitsakakis N; Johnson SR
    J Rheumatol; 2018 Oct; 45(10):1406-1410. PubMed ID: 30008448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis.
    Pope JE; Lee P; Baron M; Dunne J; Smith D; Docherty PS; Bookman A; Abu-Hakima M
    J Rheumatol; 2005 Jul; 32(7):1273-8. PubMed ID: 15996064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of pulmonary arterial hypertension in scleroderma.
    Plastiras SC; Karadimitrakis SP; Kampolis C; Moutsopoulos HM; Tzelepis GE
    Semin Arthritis Rheum; 2007 Jun; 36(6):392-6. PubMed ID: 17204309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease?
    Janardana R; Nair AM; Surin AK; Prakash JAJ; Gowri M; Danda D
    Clin Rheumatol; 2019 Nov; 38(11):3179-3187. PubMed ID: 31309339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort.
    Fretheim H; Halse AK; Seip M; Bitter H; Wallenius M; Garen T; Salberg A; Brunborg C; Midtvedt Ø; Molberg Ø; Hoffmann-Vold AM
    Rheumatology (Oxford); 2020 Oct; 59(10):2920-2929. PubMed ID: 32097470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline.
    Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Lumetti F; Luppi F; Cerri S; Ferri C
    Reumatismo; 2015 Dec; 67(4):149-55. PubMed ID: 27215180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited Exercise Capacity in Patients with Systemic Sclerosis: Identifying Contributing Factors with Cardiopulmonary Exercise Testing.
    Martis N; Queyrel-Moranne V; Launay D; Neviere R; Fuzibet JG; Marquette CH; Leroy S
    J Rheumatol; 2018 Jan; 45(1):95-102. PubMed ID: 29093153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Screening of pulmonary hypertension in a Spanish cohort of patients with systemic sclerosis].
    García Hernández FJ; Castillo Palma MJ; Montero Mateos E; González León R; López Haldón JE; Sánchez Román J
    Med Clin (Barc); 2016 Jan; 146(1):1-7. PubMed ID: 26169331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-PM-Scl antibody in patients with systemic sclerosis.
    Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
    Choi JH; Joo SJ; Kim J
    Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pulmonary hypertension in autoimmune rheumatic diseases].
    Marasini B; Massarotti M; Cossutta R; Massironi L; Mantero A
    Reumatismo; 2005; 57(2):114-8. PubMed ID: 15983635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Mortality in a Multinational Systemic Sclerosis Inception Cohort.
    Hao Y; Hudson M; Baron M; Carreira P; Stevens W; Rabusa C; Tatibouet S; Carmona L; Joven BE; Huq M; Proudman S; Nikpour M; ;
    Arthritis Rheumatol; 2017 May; 69(5):1067-1077. PubMed ID: 28029745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China.
    Zhang SZ; Xu D; Li MT; Hou Y; Wang Q; Tian Z; Liu YT; Guo XX; Lai JZ; Zhao JL; Hu CJ; Song N; Sun QN; Zhang FC; Zhao Y; Zeng XF
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S106-10. PubMed ID: 26005882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis.
    Becker M; Graf N; Sauter R; Allanore Y; Curram J; Denton CP; Khanna D; Matucci-Cerinic M; de Oliveira Pena J; Pope JE; Distler O; ;
    Ann Rheum Dis; 2019 Sep; 78(9):1242-1248. PubMed ID: 31227488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.